The willingness of healthcare institutions and professionals to adopt Polynovo's technologies and approaches to tissue repair and wound care is a crucial factor in its disruptive potential. To date there is no doubt that they are absolutely loving Polynovo products.
The extent to which Polynovo's products are validated through clinical trials and scientific research can impact their disruption within the medical field. Polynovo ticks this box in spades.
The willingness of healthcare institutions and professionals to adopt Polynovo's technologies and approaches to tissue repair and wound care is a crucial factor in its disruptive potential. They are demonstrably ready, willing and able to adopt Polynovo products.
The willingness of healthcare institutions and professionals to...
-
- There are more pages in this discussion • 1,368 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.45 |
Change
0.010(0.41%) |
Mkt cap ! $1.691B | |||
| Open | High | Low | Value | Volume |
| $2.45 | $2.51 | $2.43 | $5.243M | 2.122M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 35541 | $2.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.46 | 2681 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PNV (ASX) Chart |